A Study to Evaluate the Effect of ASP1707 on the Bodies of Healthy Male Subjects After a Single Dose of Radioactive ASP1707
PHASE1CompletedINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
August 31, 2011
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Conditions
Pharmacokinetics of ASP1707
Interventions
DRUG
14C-labeled ASP1707
oral
Trial Locations (1)
LS2 9LH
Covance CRU Ltd., Leeds
All Listed Sponsors
lead
Astellas Pharma Europe B.V.
INDUSTRY
NCT02106780 - A Study to Evaluate the Effect of ASP1707 on the Bodies of Healthy Male Subjects After a Single Dose of Radioactive ASP1707 | Biotech Hunter | Biotech Hunter